Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: Anthony@Pacific who wrote (10779)	2/11/1999 4:59:00 PM
From: Mama Bear	Read Replies (2) \| Respond to of 122088

Tony, do you really think that with all the neophytes in the market that the market makers won't take it up to sucker them in? Maybe if this wasn't the type of market that has enough idiots to take a bb stock from 1 to 6 because a company with a similar name is going to do an IPO. I recall the XMCM IPO as well, there was a bunch of idiots buying ZOOM thinking they were getting into the real thing. Barb

To: Anthony@Pacific who wrote (10779)	2/11/1999 5:07:00 PM
From: Jay Fisk	Read Replies (1) \| Respond to of 122088

RE ENMD > CNBC just finished an interview with a WSJ medical reporter who gave a good wrap on ENMD, bottom line was that the pullout of BMY yesterday FAR outweighs todays somewhat easily misinterpreted news. SS ENMD at 24 1/2 - Late confirmations and bad fills today. Will SS any gap up tomorrow - GOOD CALL !

To: Anthony@Pacific who wrote (10779)	2/11/1999 5:09:00 PM
From: M. LaMancha	Respond to of 122088

ENMD is even weaker than you might think. It is not the only company with this technology -- GZMO, a stock spin-off from Genzyme has licensed an advanced anti-angiogenesis agent from Folkman's lab in Boston. GZMO is a division of Genzyme, so it has access to and support from a manufacturing plant versed in the way to make biotechs. I bought in at 3 3/8 earlier this week, it hit 5 today and settled back a little. Who knows if gzmo will keep going, but ENMD is dead. biz.yahoo.com